Abstract
Aged dogs and humans share complex cognitive and pathological responses to aging. Specifically, dogs develop Alzheimers Disease (AD) like beta-amyloid (Aβ) that are associated with cognitive deficits. Currently, therapeutic approaches to prevent AD are targeted towards reduced production, aggregation and increased clearance of Aβ. The current review discusses cognition and neuropathology of the aging canine model and how it has and continues to be useful in further understanding the safety and efficacy of potential AD prevention therapies targeting A
Keywords: Alzheimer's disease, canine, statins, BACE-1 inhibitors, metal-chelators, A-beta vaccination
Current Neuropharmacology
Title: Therapeutic Interventions Targeting Beta Amyloid Pathogenesis in an Aging Dog Model
Volume: 9 Issue: 4
Author(s): Sarah B. Martin, Amy L.S. Dowling and Elizabeth Head
Affiliation:
Keywords: Alzheimer's disease, canine, statins, BACE-1 inhibitors, metal-chelators, A-beta vaccination
Abstract: Aged dogs and humans share complex cognitive and pathological responses to aging. Specifically, dogs develop Alzheimers Disease (AD) like beta-amyloid (Aβ) that are associated with cognitive deficits. Currently, therapeutic approaches to prevent AD are targeted towards reduced production, aggregation and increased clearance of Aβ. The current review discusses cognition and neuropathology of the aging canine model and how it has and continues to be useful in further understanding the safety and efficacy of potential AD prevention therapies targeting A
Export Options
About this article
Cite this article as:
B. Martin Sarah, L.S. Dowling Amy and Head Elizabeth, Therapeutic Interventions Targeting Beta Amyloid Pathogenesis in an Aging Dog Model, Current Neuropharmacology 2011; 9 (4) . https://dx.doi.org/10.2174/157015911798376217
DOI https://dx.doi.org/10.2174/157015911798376217 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Impaired Spatial Learning and Unaltered Neurogenesis in a Transgenic Model of Alzheimers Disease After Oral Aluminum Exposure
Current Alzheimer Research Genetic Mapping of Pharmacogenetic Regulatory Variation
Current Pharmaceutical Design QSAR and Docking Studies on Propenone Derivatives as Dual COX and 5- LOX Inhibitors
Letters in Organic Chemistry The Molecular Targets of Antitumor 2-deoxycytidine Analogues
Current Drug Targets TMS - A New Neuroimaging Combinational Tool to Study Brain Function
Current Medical Imaging Sequential Comorbidity of Anxiety and Depression in Youth: Present Knowledge and Future Directions
Current Psychiatry Reviews Association of DRD2 TaqIA and DβH -1021C>T Gene Polymorphisms with Smoking Initiation and their Interaction with Serotonergic System Gene Polymorphisms
Current Pharmacogenomics and Personalized Medicine A Multi-Endpoint Evaluation of Cytochrome P450 1A2, 2B6 and 3A4 Induction Response in Human Hepatocyte Cultures After Treatment with β - Naphthoflavone, Phenobarbital and Rifampicin
Drug Metabolism Letters Relation of Obesity to Cognitive Function: Importance of Central Obesity and Synergistic Influence of Concomitant Hypertension. The Framingham Heart Study
Current Alzheimer Research Drug Repurposing: Translational Pharmacology, Chemistry, Computers and the Clinic
Current Topics in Medicinal Chemistry Levosimendan: A Novel Agent in Heart Failure
Recent Patents on Cardiovascular Drug Discovery Beyond the HapMap Genotypic Data: Prospects of Deep Resequencing Projects
Current Bioinformatics Therapy of Acute Hepatitis C: A Review of Literature
Current Pharmaceutical Design Therapeutic Use of Molecules that Mimic Pathogen Danger Signals
Endocrine, Metabolic & Immune Disorders - Drug Targets Metal-Protein Attenuating Compounds (MPACs) for the Treatment of Alzheimers Disease
Drug Design Reviews - Online (Discontinued) Genetic Polymorphisms of Human Sulfate Transporters
Current Pharmacogenomics Intracranial MR Dynamics in Clinically Diagnosed Alzheimers Disease: The Emerging Concept of “Pulse Wave Encephalopathy”
Current Alzheimer Research Characterization of Graphs for Protein Structure Modeling and Recognition of Solubility
Current Bioinformatics In vitro And In vivo Immunomodulating Properties of Mesenchymal Stem Cells
Recent Patents on Inflammation & Allergy Drug Discovery Potential Drugs Targeting Microglia: Current Knowledge and Future Prospects
CNS & Neurological Disorders - Drug Targets